Media coverage about iKang Healthcare Group (NASDAQ:KANG) has been trending positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. iKang Healthcare Group earned a news sentiment score of 0.36 on Accern’s scale. Accern also assigned news coverage about the medical research company an impact score of 46.3910104313954 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

iKang Healthcare Group (NASDAQ:KANG) traded down $0.20 during midday trading on Friday, reaching $15.98. 393,193 shares of the company’s stock traded hands, compared to its average volume of 161,601. iKang Healthcare Group has a 1 year low of $11.70 and a 1 year high of $17.71. The company has a current ratio of 0.80, a quick ratio of 0.78 and a debt-to-equity ratio of 0.22. The company has a market cap of $1,080.00, a PE ratio of -106.53 and a beta of 0.30.

iKang Healthcare Group (NASDAQ:KANG) last posted its earnings results on Thursday, December 14th. The medical research company reported $0.29 EPS for the quarter. iKang Healthcare Group had a net margin of 0.79% and a return on equity of 1.30%.

KANG has been the subject of several recent analyst reports. BidaskClub cut shares of iKang Healthcare Group from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. TheStreet upgraded shares of iKang Healthcare Group from a “d+” rating to a “c” rating in a research report on Friday, December 15th.

TRADEMARK VIOLATION NOTICE: “Favorable News Coverage Somewhat Unlikely to Affect iKang Healthcare Group (KANG) Stock Price” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another website, it was stolen and republished in violation of US & international trademark & copyright legislation. The legal version of this article can be viewed at https://theolympiareport.com/2018/02/10/favorable-news-coverage-somewhat-unlikely-to-affect-ikang-healthcare-group-kang-stock-price.html.

About iKang Healthcare Group

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Insider Buying and Selling by Quarter for iKang Healthcare Group (NASDAQ:KANG)

Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.